Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 46
16
Diseases
490
Unique genes
0.080
Avg. similarity score
Allergic contact dermatitis
Most-connected disease (7 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Allergic contact dermatitis
Hypersensitivity
Atopic dermatitis
Autoimmune hepatitis
Rhinitis
Behcet disease
Dermatitis
Glomerulonephritis
Contact dermatitis
Giant cell arteritis
Uveitis
Autoinflammation with episodic fever and immune dysregulation
Lewis lung carcinoma
Microscopic polyangiitis
phosphohydroxylysinuria
systemic lupus erythematosus 17
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Allergic contact dermatitis | 7 | 7 | 73 |
| Hypersensitivity | 7 | 7 | 70 |
| Atopic dermatitis | 6 | 6 | 66 |
| Autoimmune hepatitis | 6 | 6 | 38 |
| Rhinitis | 6 | 6 | 65 |
| Behcet disease | 4 | 4 | 105 |
| Dermatitis | 4 | 4 | 38 |
| Glomerulonephritis | 4 | 4 | 97 |
| Contact dermatitis | 3 | 3 | 75 |
| Giant cell arteritis | 2 | 2 | 18 |
| Uveitis | 2 | 2 | 33 |
| Autoinflammation with episodic fever and immune dysregulation | 1 | 1 | 1 |
| Lewis lung carcinoma | 1 | 1 | 2 |
| Microscopic polyangiitis | 1 | 1 | 1 |
| phosphohydroxylysinuria | 1 | 1 | 1 |
| systemic lupus erythematosus 17 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| IL18 | 9 / 16 | Allergic contact dermatitis, Atopic dermatitis, Autoimmune hepatitis, Behcet disease and 5 more |
| IL10 | 8 / 16 | Allergic contact dermatitis, Atopic dermatitis, Autoimmune hepatitis, Behcet disease and 4 more |
| IL4 | 8 / 16 | Allergic contact dermatitis, Atopic dermatitis, Autoimmune hepatitis, Behcet disease and 4 more |
| TNF | 8 / 16 | Allergic contact dermatitis, Atopic dermatitis, Behcet disease, Dermatitis and 4 more |
| IFNG | 7 / 16 | Allergic contact dermatitis, Atopic dermatitis, Autoimmune hepatitis, Giant cell arteritis and 3 more |
| HLA-DRB1 | 6 / 16 | Autoimmune hepatitis, Behcet disease, Dermatitis, Giant cell arteritis and 2 more |
| IL13 | 6 / 16 | Atopic dermatitis, Autoimmune hepatitis, Dermatitis, Hypersensitivity and 2 more |
| IL1B | 6 / 16 | Atopic dermatitis, Behcet disease, Glomerulonephritis, Hypersensitivity and 2 more |
| IL2 | 6 / 16 | Allergic contact dermatitis, Atopic dermatitis, Autoimmune hepatitis, Behcet disease and 2 more |
| TLR4 | 6 / 16 | Allergic contact dermatitis, Atopic dermatitis, Behcet disease, Contact dermatitis and 2 more |
| CCL2 | 5 / 16 | Autoimmune hepatitis, Behcet disease, Giant cell arteritis, Glomerulonephritis and 1 more |
| CYP1A1 | 5 / 16 | Allergic contact dermatitis, Atopic dermatitis, Behcet disease, Contact dermatitis and 1 more |
| HLA-B | 5 / 16 | Behcet disease, Dermatitis, Giant cell arteritis, Hypersensitivity and 1 more |
| HLA-DQA1 | 5 / 16 | Autoimmune hepatitis, Dermatitis, Glomerulonephritis, Hypersensitivity and 1 more |
| IL6 | 5 / 16 | Atopic dermatitis, Autoimmune hepatitis, Glomerulonephritis, Hypersensitivity and 1 more |
| TGFB1 | 5 / 16 | Atopic dermatitis, Autoimmune hepatitis, Behcet disease, Hypersensitivity and 1 more |
| ALB | 4 / 16 | Glomerulonephritis, Hypersensitivity, Rhinitis, Uveitis |
| CCR1 | 4 / 16 | Allergic contact dermatitis, Behcet disease, Contact dermatitis, Hypersensitivity |
| CCR2 | 4 / 16 | Allergic contact dermatitis, Hypersensitivity, Rhinitis, Uveitis |
| CXCR3 | 4 / 16 | Atopic dermatitis, Contact dermatitis, Glomerulonephritis, Hypersensitivity |
| HLA-DQB1 | 4 / 16 | Autoimmune hepatitis, Behcet disease, Hypersensitivity, Rhinitis |
| MBL2 | 4 / 16 | Atopic dermatitis, Behcet disease, Giant cell arteritis, Rhinitis |
| AHR | 3 / 16 | Atopic dermatitis, Behcet disease, Contact dermatitis |
| CCL24 | 3 / 16 | Atopic dermatitis, Hypersensitivity, Rhinitis |
| CCL5 | 3 / 16 | Atopic dermatitis, Autoimmune hepatitis, Glomerulonephritis |
| CCR3 | 3 / 16 | Atopic dermatitis, Behcet disease, Rhinitis |
| CCR5 | 3 / 16 | Atopic dermatitis, Behcet disease, Uveitis |
| CTLA4 | 3 / 16 | Atopic dermatitis, Autoimmune hepatitis, Behcet disease |
| EMSY | 3 / 16 | Atopic dermatitis, Dermatitis, Rhinitis |
| FCGR3A | 3 / 16 | Behcet disease, Giant cell arteritis, Rhinitis |
| FLG | 3 / 16 | Atopic dermatitis, Contact dermatitis, Dermatitis |
| IL17A | 3 / 16 | Giant cell arteritis, Hypersensitivity, Rhinitis |
| IL23R | 3 / 16 | Behcet disease, Rhinitis, Uveitis |
| IL2RA | 3 / 16 | Allergic contact dermatitis, Dermatitis, Glomerulonephritis |
| IL5 | 3 / 16 | Allergic contact dermatitis, Atopic dermatitis, Autoimmune hepatitis |
| ITGB2 | 3 / 16 | Behcet disease, Dermatitis, Hypersensitivity |
| MS4A2 | 3 / 16 | Atopic dermatitis, Hypersensitivity, Rhinitis |
| NAT2 | 3 / 16 | Allergic contact dermatitis, Atopic dermatitis, Behcet disease |
| NOD2 | 3 / 16 | Behcet disease, Dermatitis, Rhinitis |
| SERPINE1 | 3 / 16 | Behcet disease, Glomerulonephritis, Rhinitis |
| TLR2 | 3 / 16 | Atopic dermatitis, Behcet disease, Rhinitis |
| TNFRSF1A | 3 / 16 | Behcet disease, Hypersensitivity, Uveitis |
| VDR | 3 / 16 | Atopic dermatitis, Autoimmune hepatitis, Behcet disease |
| ABCB1 | 2 / 16 | Behcet disease, Rhinitis |
| ALK | 2 / 16 | Behcet disease, Glomerulonephritis |
| BCL2 | 2 / 16 | Allergic contact dermatitis, Contact dermatitis |
| BDNF | 2 / 16 | Atopic dermatitis, Rhinitis |
| CAPSL | 2 / 16 | Dermatitis, Rhinitis |
| CASP8 | 2 / 16 | Allergic contact dermatitis, Contact dermatitis |
| CAT | 2 / 16 | Behcet disease, Rhinitis |
| CCL11 | 2 / 16 | Atopic dermatitis, Hypersensitivity |
| CCL17 | 2 / 16 | Atopic dermatitis, Hypersensitivity |
| CCL19 | 2 / 16 | Allergic contact dermatitis, Hypersensitivity |
| CCL3 | 2 / 16 | Glomerulonephritis, Hypersensitivity |
| CCL4 | 2 / 16 | Glomerulonephritis, Hypersensitivity |
| CCL7 | 2 / 16 | Glomerulonephritis, Hypersensitivity |
| CDH19 | 2 / 16 | Glomerulonephritis, Microscopic polyangiitis |
| CLDN1 | 2 / 16 | Atopic dermatitis, Contact dermatitis |
| CLEC16A | 2 / 16 | Dermatitis, Rhinitis |
| CXCL1 | 2 / 16 | Autoimmune hepatitis, Hypersensitivity |
| CXCL8 | 2 / 16 | Behcet disease, Glomerulonephritis |
| CYP2D6 | 2 / 16 | Autoimmune hepatitis, Rhinitis |
| DSG1 | 2 / 16 | Dermatitis, Hypersensitivity |
| EGFR | 2 / 16 | Behcet disease, Dermatitis |
| ERAP1 | 2 / 16 | Behcet disease, Uveitis |
| F2 | 2 / 16 | Autoimmune hepatitis, Glomerulonephritis |
| FAS | 2 / 16 | Behcet disease, Glomerulonephritis |
| GLB1 | 2 / 16 | Atopic dermatitis, Contact dermatitis |
| GSTP1 | 2 / 16 | Atopic dermatitis, Contact dermatitis |
| HLA-A | 2 / 16 | Dermatitis, Uveitis |
| HMOX1 | 2 / 16 | Contact dermatitis, Rhinitis |
| HNMT | 2 / 16 | Atopic dermatitis, Rhinitis |
| IL1A | 2 / 16 | Allergic contact dermatitis, Behcet disease |
| IL1RN | 2 / 16 | Glomerulonephritis, Rhinitis |
| IL21R | 2 / 16 | Behcet disease, Giant cell arteritis |
| IL33 | 2 / 16 | Atopic dermatitis, Hypersensitivity |
| IL4R | 2 / 16 | Atopic dermatitis, Rhinitis |
| LEP | 2 / 16 | Autoimmune hepatitis, Rhinitis |
| MRC1 | 2 / 16 | Allergic contact dermatitis, Rhinitis |
| MTHFR | 2 / 16 | Glomerulonephritis, Hypersensitivity |
| PHYKPL | 2 / 16 | Glomerulonephritis, phosphohydroxylysinuria |
| PTPN22 | 2 / 16 | Behcet disease, Giant cell arteritis |
| S100A8 | 2 / 16 | Atopic dermatitis, Contact dermatitis |
| SELE | 2 / 16 | Allergic contact dermatitis, Atopic dermatitis |
| SELP | 2 / 16 | Atopic dermatitis, Hypersensitivity |
| SHARPIN | 2 / 16 | Autoinflammation with episodic fever and immune dysregulation, Dermatitis |
| SLC11A1 | 2 / 16 | Atopic dermatitis, Behcet disease |
| SPP1 | 2 / 16 | Allergic contact dermatitis, Hypersensitivity |
| STAT4 | 2 / 16 | Autoimmune hepatitis, Behcet disease |
| TLR7 | 2 / 16 | Allergic contact dermatitis, systemic lupus erythematosus 17 |
| TSLP | 2 / 16 | Atopic dermatitis, Hypersensitivity |
| TXNRD1 | 2 / 16 | Contact dermatitis, Lewis lung carcinoma |
| VEGFA | 2 / 16 | Contact dermatitis, Glomerulonephritis |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Cytokine-cytokine receptor interaction | KEGG | 85 / 298 | 7.0× | 3.68e-49 | 4.51e-45 ✓ sig. |
| Viral protein interaction with cytokine and cytokine receptor | KEGG | 48 / 100 | 11.8× | 2.84e-40 | 1.96e-36 ✓ sig. |
| Inflammatory bowel disease | KEGG | 38 / 66 | 14.1× | 4.65e-36 | 2.16e-32 ✓ sig. |
| Interleukin-10 signaling | Reactome | 31 / 47 | 16.2× | 2.76e-32 | 9.82e-29 ✓ sig. |
| Interleukin-4 and Interleukin-13 signaling | Reactome | 43 / 108 | 9.8× | 6.90e-32 | 2.31e-28 ✓ sig. |
| Chemokine receptors bind chemokines | Reactome | 31 / 59 | 12.9× | 6.44e-28 | 1.58e-24 ✓ sig. |
| Rheumatoid arthritis | KEGG | 33 / 95 | 8.5× | 1.79e-22 | 2.27e-19 ✓ sig. |
| Th17 cell differentiation | KEGG | 34 / 109 | 7.6× | 2.18e-21 | 2.19e-18 ✓ sig. |
| JAK-STAT signaling pathway | KEGG | 41 / 168 | 6.0× | 4.49e-21 | 4.31e-18 ✓ sig. |
| Lipid and atherosclerosis | KEGG | 44 / 216 | 5.0× | 3.14e-19 | 2.28e-16 ✓ sig. |
| Chemokine signaling pathway | KEGG | 41 / 193 | 5.2× | 1.09e-18 | 7.32e-16 ✓ sig. |
| IL-17 signaling pathway | KEGG | 29 / 94 | 7.6× | 2.88e-18 | 1.76e-15 ✓ sig. |
| Tuberculosis | KEGG | 39 / 181 | 5.3× | 4.69e-18 | 2.75e-15 ✓ sig. |
| Allograft rejection | KEGG | 19 / 39 | 11.9× | 9.19e-17 | 4.16e-14 ✓ sig. |
| Malaria | KEGG | 21 / 50 | 10.3× | 9.81e-17 | 4.42e-14 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| immune response | GO:0006955 | 107 / 543 | 7.5× | 1.62e-63 | 8.10e-59 ✓ sig. |
| inflammatory response | GO:0006954 | 96 / 467 | 7.8× | 1.62e-58 | 5.16e-54 ✓ sig. |
| chemotaxis | GO:0006935 | 42 / 161 | 9.9× | 3.75e-30 | 1.99e-26 ✓ sig. |
| antimicrobial humoral immune response mediated by antimicrobial peptide | GO:0061844 | 35 / 124 | 10.8× | 1.39e-26 | 5.07e-23 ✓ sig. |
| positive regulation of inflammatory response | GO:0050729 | 33 / 122 | 10.3× | 1.80e-24 | 5.30e-21 ✓ sig. |
| cytokine-mediated signaling pathway | GO:0019221 | 35 / 145 | 9.2× | 4.66e-24 | 1.33e-20 ✓ sig. |
| cellular response to lipopolysaccharide | GO:0071222 | 38 / 187 | 7.7× | 3.91e-23 | 1.01e-19 ✓ sig. |
| response to lipopolysaccharide | GO:0032496 | 35 / 161 | 8.3× | 2.00e-22 | 4.58e-19 ✓ sig. |
| chemokine-mediated signaling pathway | GO:0070098 | 24 / 64 | 14.3× | 6.07e-22 | 1.28e-18 ✓ sig. |
| positive regulation of type II interferon production | GO:0032729 | 23 / 77 | 11.4× | 1.68e-18 | 2.18e-15 ✓ sig. |
| positive regulation of gene expression | GO:0010628 | 53 / 504 | 4.0× | 5.17e-18 | 6.20e-15 ✓ sig. |
| killing of cells of another organism | GO:0031640 | 25 / 104 | 9.2× | 1.74e-17 | 1.95e-14 ✓ sig. |
| positive regulation of canonical NF-kappaB signal transduction | GO:0043123 | 35 / 232 | 5.8× | 4.69e-17 | 4.82e-14 ✓ sig. |
| cell surface receptor signaling pathway | GO:0007166 | 44 / 373 | 4.5× | 5.73e-17 | 5.81e-14 ✓ sig. |
| positive regulation of tumor necrosis factor production | GO:0032760 | 25 / 113 | 8.4× | 1.46e-16 | 1.34e-13 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Atopic dermatitis | Rhinitis | 0.158 | 18 | 8.10e-29 | 2.51e-27 ✓ sig. |
| Atopic dermatitis | Hypersensitivity | 0.151 | 18 | 3.72e-28 | 1.12e-26 ✓ sig. |
| Atopic dermatitis | Behcet disease | 0.117 | 18 | 1.16e-24 | 2.93e-23 ✓ sig. |
| Behcet disease | Rhinitis | 0.110 | 17 | 5.51e-23 | 1.26e-21 ✓ sig. |
| Hypersensitivity | Rhinitis | 0.115 | 14 | 2.06e-20 | 4.24e-19 ✓ sig. |
| Atopic dermatitis | Autoimmune hepatitis | 0.129 | 12 | 3.32e-20 | 6.76e-19 ✓ sig. |
| Autoimmune hepatitis | Hypersensitivity | 0.124 | 12 | 7.12e-20 | 1.43e-18 ✓ sig. |
| Hypersensitivity | Uveitis | 0.118 | 11 | 1.35e-18 | 2.52e-17 ✓ sig. |
| Behcet disease | Giant cell arteritis | 0.088 | 10 | 5.86e-18 | 1.06e-16 ✓ sig. |
| Glomerulonephritis | Hypersensitivity | 0.091 | 14 | 8.48e-18 | 1.52e-16 ✓ sig. |
| Autoimmune hepatitis | Rhinitis | 0.106 | 10 | 3.75e-16 | 6.12e-15 ✓ sig. |
| Allergic contact dermatitis | Atopic dermatitis | 0.085 | 11 | 1.08e-14 | 1.60e-13 ✓ sig. |
| Atopic dermatitis | Contact dermatitis | 0.076 | 10 | 6.85e-13 | 8.87e-12 ✓ sig. |
| Allergic contact dermatitis | Hypersensitivity | 0.075 | 10 | 9.57e-13 | 1.23e-11 ✓ sig. |
| Autoimmune hepatitis | Glomerulonephritis | 0.071 | 9 | 1.50e-12 | 1.89e-11 ✓ sig. |
| Dermatitis | Rhinitis | 0.083 | 8 | 2.86e-12 | 3.47e-11 ✓ sig. |
| Dermatitis | Hypersensitivity | 0.079 | 8 | 5.30e-12 | 6.32e-11 ✓ sig. |
| Allergic contact dermatitis | Rhinitis | 0.069 | 9 | 1.88e-11 | 2.13e-10 ✓ sig. |
| Allergic contact dermatitis | Behcet disease | 0.059 | 10 | 6.11e-11 | 6.57e-10 ✓ sig. |
| Autoimmune hepatitis | Giant cell arteritis | 0.096 | 5 | 5.83e-10 | 5.70e-9 ✓ sig. |
| Dermatitis | Uveitis | 0.075 | 5 | 1.57e-8 | 1.31e-7 ✓ sig. |
| Allergic contact dermatitis | Autoimmune hepatitis | 0.057 | 6 | 2.25e-8 | 1.85e-7 ✓ sig. |
| Allergic contact dermatitis | Contact dermatitis | 0.042 | 6 | 1.43e-6 | 8.64e-6 ✓ sig. |
| Autoinflammation with episodic fever and immune dysregulation | Dermatitis | 0.026 | 1 | 2.47e-3 | 3.36e-3 ✓ sig. |
| Allergic contact dermatitis | systemic lupus erythematosus 17 | 0.014 | 1 | 4.74e-3 | 5.86e-3 ✓ sig. |
| Glomerulonephritis | Microscopic polyangiitis | 0.010 | 1 | 6.30e-3 | 7.57e-3 ✓ sig. |
| Glomerulonephritis | phosphohydroxylysinuria | 0.010 | 1 | 6.30e-3 | 7.57e-3 ✓ sig. |
| Contact dermatitis | Lewis lung carcinoma | 0.013 | 1 | 9.72e-3 | 1.10e-2 ✓ sig. |